Literature DB >> 26028046

Advances in Hyaluronic Acid-Based Drug Delivery Systems.

Yan Jiao, Xin Pang, Guangxi Zhai1.   

Abstract

Hyaluronic acid (HA) is a relatively new polymer for the construction of drug delivery systems. CD44 and the receptor for HA-mediated motility play a key role in vivo for the receptor-mediated endocytosis of HA. Cellular uptake and the efficiency of tumor-targeted drug delivery are supposed to increase through utilizing HA as drug carriers. Currently, HA has provided a promising platform to physically encapsulate or chemically conjugate with various drugs. In this review, we presented the most latest advances in HA-based drug delivery systems and some forward-looking ideas are discussed.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26028046     DOI： 10.2174/1389450116666150531155200

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN： 1389-4501            Impact factor:   3.465


  9 in total

1.  Synthesis and characterization of hyaluronic acid hydrogels crosslinked using a solvent-free process for potential biomedical applications.

Authors:  Eneko Larrañeta; Megan Henry; Nicola J Irwin; Johann Trotter; Anastasia A Perminova; Ryan F Donnelly
Journal:  Carbohydr Polym       Date:  2017-12-07       Impact factor: 9.381

Review 2.  Smart Carriers and Nanohealers: A Nanomedical Insight on Natural Polymers.

Authors:  Sreejith Raveendran; Ankit K Rochani; Toru Maekawa; D Sakthi Kumar
Journal:  Materials (Basel)       Date:  2017-08-10       Impact factor: 3.623

3.  Biocompatibility of Gd-Loaded Chitosan-Hyaluronic Acid Nanogels as Contrast Agents for Magnetic Resonance Cancer Imaging.

Authors:  Cecilia Virginia Gheran; Guillaume Rigaux; Maité Callewaert; Alexandre Berquand; Michael Molinari; Françoise Chuburu; Sorina Nicoleta Voicu; Anca Dinischiotu
Journal:  Nanomaterials (Basel)       Date:  2018-03-28       Impact factor: 5.076

Review 4.  Hyaluronic Acid: A Review of the Drug Delivery Capabilities of This Naturally Occurring Polysaccharide.

Authors:  Ciara Buckley; Emma J Murphy; Therese R Montgomery; Ian Major
Journal:  Polymers (Basel)       Date:  2022-08-23       Impact factor: 4.967

5.  Multimodal Magnetic Resonance and Photoacoustic Imaging of Tumor-Specific Enzyme-Responsive Hybrid Nanoparticles for Oxygen Modulation.

Authors:  Maharajan Sivasubramanian; Chia-Hui Chu; Shih-Hsun Cheng; Nai-Tzu Chen; Chin-Tu Chen; Yao Chen Chuang; Hsia Yu; Yu-Lin Chen; Lun-De Liao; Leu-Wei Lo
Journal:  Front Bioeng Biotechnol       Date:  2022-07-13

Review 6.  Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment.

Authors:  Simran Nasra; Dhiraj Bhatia; Ashutosh Kumar
Journal:  Nanoscale Adv       Date:  2022-07-26

Review 7.  Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems.

Authors:  Rajiv Bajracharya; Jae Geun Song; Basavaraj Rudragouda Patil; Sang Hoon Lee; Hye-Mi Noh; Da-Hyun Kim; Gyu-Lin Kim; Soo-Hwa Seo; Ji-Won Park; Seong Hoon Jeong; Chang Hoon Lee; Hyo-Kyung Han
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 8.  Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy.

Authors:  Aikaterini Berdiaki; Monica Neagu; Eirini-Maria Giatagana; Andrey Kuskov; Aristidis M Tsatsakis; George N Tzanakakis; Dragana Nikitovic
Journal:  Biomolecules       Date:  2021-03-08

Review 9.  Nanomaterials Manipulate Macrophages for Rheumatoid Arthritis Treatment.

Authors:  Shuang Li; Jin Su; Wei Cai; Jian-Xin Liu
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.